Dassault Systèmes And Accelrys merge

Dassault Systèmes, the 3Dexperience Company, and Accelrys, Inc., provider of software for the management of the cycle of life of the scientific innovation, announces the signature of a definite agreement of fusion in virtue of the cual Dassault Systèmes will purchase the company Accelrys, Inc. (Accelrys) with headquarters in San Diego. Under the terms and conditions of the agreement of fusion, Dassault Systèmes will realizar a public offer of actions in cash for all the actions in circulation of the common stock of Accelrys, to a price of 12,50 dollars by action, without interest, what represents a complete value diluted for Accelrys of roughly 750 million dollars. Dassault Systèmes Has the intention to purchase any action of Accelrys that was not included in the offer, through a fusion that will be effective the before possible after the closing of the public offer of purchase.

The combination with Accelrys will enrich the capacities of molecular chemicals -from the discovery to the manufacture and the normative requirements- of the solutions of Dassault Systèmes headed to the industries that use the formulation, like the sciences of the health, the goods of consumption packed, the high technology and the power, as well as the industries of manufacture advanced.

“With Max Carnecchia and his equipment, share the same passion to make possible the scientific innovation and are safe that, together, taking advantage of the big active of Accelrys, will offer a solution PLM only scientist and without rival in the market”, signals Bernard Charlès, president and CEO of Dassault Systèmes. “The world sues a new paradigm of sustainability in which confluyan the chemicals, the materials and the biology. Precisely this is what supply the virtual universes that does possible Dassault Systèmes, able to harmonise products, nature and life, from the imagination to the experience of industrial solution”.

The list of 2.000 customers of Accelrys includes to many of the companies of the index Fortune 500, with big players of the pharmaceutical industry and biotecnológica, the goods of consumption packed and the chemical industry, including to Sanofi, Pfizer, GSK, AstraZeneca, Du Pont, Shell, BASF, P&G, Unilever and L'Oréal.

The managerial board of Accelrys has approved unanimously the transaction. It expects that the transaction was completed during the second quarter of 2014, subject to that the shareholders of Accelrys offer a majority of the actions in circulation of Accelrys in the public offer that it will be launched in the next days, after receiving the timely approvals regulatorias and fulfil other conditions of usual closing.

Forums has acted like financial adviser and Cravath, Swaine & Moore LLP have supplied the legal quality consultancy to Dassault Systèmes. Accelrys Has been advised by Morgan Stanley & Co. LLC, and Paul Hastings LLP in the legal field.

The past 30 January, Dassault Systèmes celebrated a conference to explain the details of the agreement. The conference will be available during 30 days in the steering: http://www.3ds.com/investors/.

Dassault Systèmes Will announce his corresponding income to the fourth quarter and to all the fiscal year 2013 the next 6 February. By his part, Accelrys will communicate his corresponding income to the fourth quarter and to all the fiscal year 2013 the next 25 February.